10-101131807-G-A
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_005521.4(TLX1):c.266G>A(p.Gly89Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000525 in 1,389,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005521.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TLX1 | NM_005521.4 | c.266G>A | p.Gly89Asp | missense_variant | Exon 1 of 3 | ENST00000370196.11 | NP_005512.1 | |
TLX1 | NM_001195517.2 | c.266G>A | p.Gly89Asp | missense_variant | Exon 1 of 3 | NP_001182446.1 | ||
TLX1 | XM_011539744.4 | c.266G>A | p.Gly89Asp | missense_variant | Exon 1 of 3 | XP_011538046.1 | ||
TLX1NB | NR_130724.1 | n.580-4709C>T | intron_variant | Intron 1 of 2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152086Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 15814 AF XY: 0.00
GnomAD4 exome AF: 0.0000226 AC: 28AN: 1237458Hom.: 0 Cov.: 31 AF XY: 0.0000216 AC XY: 13AN XY: 602366 show subpopulations
GnomAD4 genome AF: 0.000296 AC: 45AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000255 AC XY: 19AN XY: 74396 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.266G>A (p.G89D) alteration is located in exon 1 (coding exon 1) of the TLX1 gene. This alteration results from a G to A substitution at nucleotide position 266, causing the glycine (G) at amino acid position 89 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at